Global /United States /Healthcare /Biotechnology /IVRO
chevron_leftBack
InVitro International, Inc. logo

InVitro International, Inc.

IVRO
OTCMKTS: IVRO Delayed
0.0887USD 0%
As of 9 June 2026, InVitro International, Inc. has a market cap of $1.97M USD, ranking #47215 globally and #5998 in the United States. It ranks #4185 in the Healthcare sector, and #818 in the Biotechnology industry.
Global Rank
47215
Country Rank
5998
Sector Rank
4185
Industry Rank
818
Key Stats
Market Cap
$1.97MUSD
Enterprise Value
$1.04MUSD
Revenue (TTM)
$811.29KUSD
EBITDA (TTM)
$72.69KUSD
Net Income (TTM)
$106.7KUSD
EBITDA Margin
9%
Profit Margin
13%
PE Ratio
22.2
PS Ratio
2.4
PB Ratio
1.3
EV/EBITDA
8.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
W. Ulmer open_in_new
Employees
16
Founded
1985
Website
invitrointl.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 11% -0.3% -37% 7% -11%
Upcoming Earnings
Earnings Date
Tue, Jun 23

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
IVRO
Invitro International
ISIN: US4618531036
Shares Out.:
22.16M1
TV:
SA:
YF:
GF:
BA:
MS:
0.0887 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About InVitro International, Inc.

InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
9M%
23.9
GILD
$159.92B
8M%
19.0
NTRA
$27.6B
1M%
-
$26.3B
1M%
20.0
$25.03B
1M%
20.4
MRNA
$18.13B
918K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.69B
41.39B EUR
2M%
39.9
$43.73B
68.19T KRW
2M%
35.5
CSL
$42.5B
60.27B AUD
2M%
29.3
LONN
$42.49B
33.71B CHF
2M%
37.2
068270
$27.42B
42.76T KRW
1M%
43.8
BNTX
$25.69B
1M%
-
chevron_leftBack